Contemporary Pediatrics asked pediatric infectious diseases experts how community pediatricians can talk with families who are firmly against vaccinating their children or hesitant to do so. Here’s what they said.
Pediatricians are wrestling with how they should deal with a growing antivaccination movement-one that’s taking a heavy toll on population health.1
Take measles, for example. “The resurgence in measles cases is all the more frustrating since the disease is entirely preventable through vaccination,” according to the perspective “Measles in 2019-Going backward” by Catherine I. Paules, MD, and colleagues, published April 17, 2019, at NEJM.org.1 “The growing antivaccination movement, based heavily on philosophical objections to vaccinations, poses a threat to public health,” Paules writes. “Vaccine hesitancy has been identified by the World Health Organization (WHO) as one of the top 10 threats to global health and is a serious hurdle to the global elimination and eradication of measles.”
So, how does a pediatrician charged with doing no harm help, care for, and come to terms with families who are firmly against vaccinating their children or hesitant to do so? We asked several pediatric infectious disease control experts for their advice.
Change the equation: The risk of vaccines is greater than the risk of disease
Craft the message: Vaccines are routine, safe, preventive medicine
Speak from the heart about vaccines
Know your audience, acknowledge specific concerns
The vaccine discussion: A frustrating but necessary investment in time
1. Paules CI, Marston HD, Fauci AS. Measles in 2019-going backward. N Engl J Med. 2019;380(23):2185-2187. Available at: https://www.nejm.org/doi/full/10.1056/NEJMp1905099. Accessed June 21, 2019.
BNT162b2 COVID vaccine effective in children amid Delta, Omicron periods
January 17th 2024Investigators of a study published in Annals of Internal Medicine concluded that the BNT162b2 COVID-19 vaccine demonstrated efficacy against the Delta and Omicron variants of COVID-19 in children and adolescents, offering new, extended follow-up period data.
BNT162b2 COVID vaccine effective in children amid Delta, Omicron periods
January 17th 2024Investigators of a study published in Annals of Internal Medicine concluded that the BNT162b2 COVID-19 vaccine demonstrated efficacy against the Delta and Omicron variants of COVID-19 in children and adolescents, offering new, extended follow-up period data.
2 Commerce Drive
Cranbury, NJ 08512